Pharma
Co-development agreement with US insulin pump device company for AT278 and sale of royalty and technology access fees for up to $11 million
This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR"). Arecor Therapeutics plc(“Arecor” or the “Company”)Co-development Agreement with US Insulin Pump Device Company for AT...
Daiichi Sankyo joins Milner Therapeutics Consortium
Daiichi Sankyo has joined the Milner Therapeutics Consortium as our tenth pharma partner. ...
Reimagining COPD care for 450 million people: A global mission at scale
A global epidemicCOPD is a silent killer. It is the third leading cause of death worldwide, taking three million lives annually. More than 450 million are diagnosed, and the actual number may reach 900 million when undiagnosed cases are counted. In the EU, COPD costs €38.6 billion annua...
Beyond the inhaler: Why the future of COPD care is digital, continuous, and predictive
Inhalers: life-saving, but not enoughFor decades, inhalers have been the cornerstone of COPD care. They improve symptoms and prolong life. But adherence is low — often less than 50% — and monitoring is sporadic. Patients are frequently left unobserved for long stretches, during which th...
The smartphone revolution in lung health: Foundations for the future
Spirometry: A century-old tool in need of reinventionFor more than a century, spirometry has been the foundation of respiratory medicine. Yet despite its clinical importance, the test remains hospital-bound, tied to bulky equipment and reliant on maximal voluntary effort. Patients often...
588 IND Filings Worldwide
We're proud to share that Medicilon has now supported 588 IND filings.
25 Years of Guardtech – a new era for cleanroom furniture & equipment fit-outs with Guardware
Suffolk-based cleanroom construction specialists the Guardtech Group have launched a new cleanroom furniture & equipment website to take their Guardware Cleanroom Hardware brand to the next level. ...
Looking to the future of intratumoural drug delivery
Drug treatments serve as a vital line of defence alongside surgery and radiotherapy. They include chemotherapy, hormone therapy, immunotherapy and targeted therapy. Most drug treatments are delivered systemically, circulating through the bloodstream to reach cancer cells. Systemic cance...
Closed Loop Medicine launches first personalized GLP-1 dosing platform in U.S.
WeDosify becomes CLM’s first commercially available product – delivering data-driven, adaptive dosing recommendations to improve GLP-1 adherence.Informed by 29 studies and 15,000+ patient profiles; developed to tailor GLP-1 titration and reduce side effects. London, UK, September 1...
Taming the untamable: Medicilon Powers KRAS-targeted therapies
KRAS is one of the most frequently mutated oncogenes in human cancers. Once thought “undruggable,” recent scientific advances have enabled the development of therapies targeting KRAS mutations, especially G12C, G12D, and G13D. ...